DarioHealth (DRIO) Other financing activities (2013 - 2021)

DarioHealth's (DRIO) quarterly Other financing activities came in at -$377000.0 in Q4 2021, down 159.56% on a QoQ basis from $633000.0 in Q1 2021.

DarioHealth (DRIO) Other financing activities (2013 - 2021) Analysis & Trends

DarioHealth (DRIO) has 2 years of Other financing activities data on file, last reported at -$377000.0 in Q4 2021.

Quarterly Other financing activities changed N/A year-over-year to -$377000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $256000.0 (changed N/A YoY) and the FY2021 annual result came in at $256000.0, changed N/A from the prior year.
Other financing activities slipped to -$377000.0 in Q4 2021, from $633000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $633000.0 in Q1 2021 to a low of -$377000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	DarioHealth	70.92 Mn	56.96 Mn	3.19 Mn

Download Data